Floatz logo

HUMAN IMMUNOGLOBULINS

Common Variable Immunodeficiency

Grifols Therapeutics LLCother_biologicalPhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Common Variable Immunodeficiency cohort.

Asset / SponsorPhaseRating
Conestat Alfa
IMMUNOe Research Centers
Phase 4BB
Thiotepa
University of Florida
Phase 2BB
Fludarabine
Washington University School of Medicine
Phase 2CCC
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Paul Szabolcs
Phase 2CCC
Evomela
Paul Szabolcs
Phase 2CCC

View all 19 →

Same molecule, other indications

HUMAN IMMUNOGLOBULINS is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
70 / 100
View asset →
Post-Polio SyndromeDormant
BB
Indicative ·
67 / 100
View asset →
epilepsyDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →